STOCK TITAN

BNB Plus (NASDAQ: BNBX) details $2.5M preferred sale and $1.72M warrant cash

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K/A

Rhea-AI Filing Summary

BNB Plus Corp. filed an amendment describing completed and updated financing transactions. The company closed a Securities Purchase Agreement on May 28, 2026, selling 2,380,953 shares of Series B-1 Preferred Stock and issuing Common Warrants for 2,380,953 common shares at $1.05 per share, for gross proceeds of $2.5 million.

The amendment also notes a new Inducement Agreement entered on May 31, 2026 tied to Series E Warrant exercises of about $0.22 million, and updates that initial closings under the Inducement Agreements are expected to generate approximately $1.72 million in aggregate gross proceeds on or before June 9, 2026. These securities were issued in private placements relying on exemptions from SEC registration.

Positive

  • None.

Negative

  • None.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Series B-1 Preferred issued 2,380,953 shares Sold under SPA on May 28, 2026
Common Warrants issued 2,380,953 warrants Purchase rights for common shares under SPA
Offering price $1.05 per share Price for Series B-1 Preferred Stock
Gross proceeds from SPA $2.5 million Cash received from purchaser
Additional warrant exercise amount approximately $0.22 million Series E Warrant exercise by added Exchanging Holder
Expected Inducement proceeds approximately $1.72 million Anticipated aggregate gross proceeds from Inducement Agreements
Expected initial closing date on or before June 9, 2026 Initial closing for Inducement Agreements
Securities Purchase Agreement financial
"entry into (1) a Securities Purchase Agreement (“SPA”) with an accredited investor"
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
Inducement Agreement financial
"Warrant Inducement and Exchange Agreements (each an “Inducement Agreement”), with certain investors"
Series B-1 Preferred Stock financial
"agreed to purchase Series B-1 Preferred Stock, and/or Series B-1 Prefunded Warrants"
Series E Warrants financial
"exercise for cash a certain percentage of outstanding Series E Common Stock Purchase Warrants"
Regulation D regulatory
"pursuant to Section 4(a)(1) thereof and/or Rule 506(b) of Regulation D"
Regulation D is a set of rules that govern how companies can raise money from investors without going through the full process required for public stock offerings. It provides simplified options for private placements, making it easier for companies to seek investments from a smaller group of investors. For investors, it offers opportunities to invest in private companies, often with fewer restrictions, but also with different levels of risk and disclosure.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0000744452 0000744452 2026-05-26 2026-05-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K/A

Amendment No. 1

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): May 26, 2026

  

BNB Plus Corp.

(Exact name of registrant as specified in its charter)

  

Delaware

(State or other jurisdiction

of incorporation)

001-36745

(Commission File Number)

59-2262718

(IRS Employer

Identification No.)

 

25 Health Sciences Drive

Stony Brook, New York 11790

(Address of principal executive offices) (Zip Code)

  

631-240-8800

(Registrants’ telephone number, including area code)

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading
Symbol(s)
  Name of each exchange on which registered
Common Stock, $0.001 par value   BNBX   The Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company    ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Explanatory Note

 

On May 27, 2026, BNB Plus Corp., a Delaware corporation (the “Company”), filed a Current Report on Form 8-K (the “Original 8-K”) related to the entry into (1) a Securities Purchase Agreement (“SPA”) with an accredited investor (the “Purchaser”), pursuant to which the purchaser (“Purchaser”) agreed to purchase Series B-1 Preferred Stock, and/or Series B-1 Prefunded Warrants in lieu thereof, and Common Warrants, at an offering price of $1.05 per share for an aggregate subscription amount of $2.5 million, and; (2) Warrant Inducement and Exchange Agreements (each an “Inducement Agreement”), with certain investors (each an “Exchanging Holder”) who participated in the Company’s private placements that closed on October 3, 2025 and October 23, 2025 (collectively the “2025 PIPE”), whereby each Exchanging Holder agreed to (i) exercise for cash a certain percentage of outstanding Series E Common Stock Purchase Warrants (the “Series E Warrants”); (ii) exchange common stock of the Company, par value $0.001 per share (“Common Stock”); and (iii) exchange pre-funded warrants, held by the Exchanging Holder, to receive convertible preferred stock and other securities, as described in the Original 8-K.

 

The Original 8-K described the terms of the transactions contemplated by the SPA and Inducement Agreements and this Amendment No. 1 to Current Report on Form 8-K/A (this “Amendment”) is being filed to supplement the Original 8-K to (1) report the total number of Series B-1 Preferred Stock and Common Warrants issued at the closing of the SPA on May 28, 2026, (2) report the entry into an Inducement Agreement with an additional Exchanging Holder, (3) update the aggregate amount expected upon exercise of Series E Warrants under the Inducement Agreements, and (4) update the expected timing of the initial closing of the Inducement Agreement.

 

Except as expressly set forth herein, this Amendment does not amend the Original 8-K in any way and does not modify or update any other disclosures contained in the Original 8-K. This Amendment supplements the Original 8-K and should be read in conjunction with the Original 8-K. Except as defined herein, Capitalized terms have the same meaning as defined in the Original 8-K.

 

Item 3.02 Unregistered Sales of Equity Securities

 

On May 28, 2026, the Company closed the transaction contemplated by the SPA and sold and issued to the Purchaser, at an offering price of $1.05 per share, 2,380,953 shares of Series B-1 Preferred Stock and Common Warrants to purchase 2,380,953 shares of Common Stock. Gross proceeds from the SPA totaled $2.5 million.

 

On May 31, 2026, the Company entered into an Inducement Agreement with an Exchanging Holder for an exercise of Series E Warrants in an aggregate amount of approximately $0.22 million. The initial closing of the Inducement Agreements entered into on May 26, 2026 and May 31, 2026, for anticipated aggregate gross proceeds of approximately $1.72 million, is expected to occur on or before June 9, 2026.

 

The issuance by the Company of the Series B-1 Preferred Stock and Common Warrants in connection with the SPA, and the offer of Preferred Stock, Preferred Stock Shares, Prefunded Warrants, Prefunded Warrant Shares, Rights, Common Warrants, and Common Warrant Shares pursuant to the SPA and Inducement Agreements, was made in reliance upon the exemption from the registration requirement of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(1) thereof and/or Rule 506(b) of Regulation D promulgated thereunder, and applicable state securities laws. The securities that were issued pursuant to the SPA have not been registered under the Securities Act and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act and any applicable state securities laws.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BNB Plus Corp.
     
Date: June 3, 2026 By:   /s/ Clay Shorrock
  Name: Clay Shorrock
  Title: Chief Executive Officer

 

 

FAQ

What financing did BNBX complete under the Securities Purchase Agreement?

BNB Plus Corp. completed a private financing by selling 2,380,953 shares of Series B-1 Preferred Stock and issuing Common Warrants for 2,380,953 common shares at $1.05 per share, generating gross proceeds of $2.5 million from the accredited investor purchaser.

What is the purpose of the Inducement Agreements mentioned by BNBX?

The Inducement Agreements encourage certain investors from BNB Plus Corp.’s 2025 private placements to exercise Series E Warrants for cash and exchange existing securities, in return for new preferred stock and related securities, as outlined in the original disclosure and updated by this amendment.

How much additional cash does BNBX expect from the Series E Warrant exercises?

BNB Plus Corp. reports that initial closings of Inducement Agreements entered on May 26 and May 31, 2026 are anticipated to produce approximately $1.72 million in aggregate gross proceeds, including about $0.22 million of Series E Warrant exercises by an additional Exchanging Holder.

When are the initial closings of BNBX’s Inducement Agreements expected?

BNB Plus Corp. states that the initial closing of the Inducement Agreements executed on May 26, 2026 and May 31, 2026 is expected to occur on or before June 9, 2026, tied to cash exercises of Series E Warrants and related exchanges.

Were BNBX’s new preferred stock and warrants registered with the SEC?

The Series B-1 Preferred Stock, Common Warrants and related securities were issued by BNB Plus Corp. in private transactions relying on exemptions under Section 4(a)(1) and Rule 506(b) of Regulation D, and have not been registered under the Securities Act of 1933.

What types of securities are involved in BNBX’s SPA and Inducement deals?

BNB Plus Corp.’s transactions involve Series B-1 Preferred Stock, Common Warrants, Prefunded Warrants, Preferred Stock Shares, Prefunded Warrant Shares, Rights and Common Warrant Shares, which are offered in connection with the Securities Purchase Agreement and related Inducement Agreements.

Filing Exhibits & Attachments

3 documents